These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1663954

  • 1. Dysregulation of the hypothalamo-pituitary-adrenal axis and duration of diabetes.
    Roy M, Collier B, Roy A.
    J Diabet Complications; 1991; 5(4):218-20. PubMed ID: 1663954
    [Abstract] [Full Text] [Related]

  • 2. Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients.
    Roy M, Collier B, Roy A.
    Psychiatry Res; 1990 Jan; 31(1):31-7. PubMed ID: 2156275
    [Abstract] [Full Text] [Related]

  • 3. Hyperactivity of the hypothalamic-pituitary-adrenal axis in patients with type 2 diabetes and relations with insulin resistance and chronic complications.
    Prpić-Križevac I, Canecki-Varžić S, Bilić-Ćurčić I.
    Wien Klin Wochenschr; 2012 Jun; 124(11-12):403-11. PubMed ID: 22733309
    [Abstract] [Full Text] [Related]

  • 4. Increased urinary-free cortisol outputs in diabetic patients.
    Roy MS, Roy A, Brown S.
    J Diabetes Complications; 1998 Jun; 12(1):24-7. PubMed ID: 9442811
    [Abstract] [Full Text] [Related]

  • 5. Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity.
    Chan O, Inouye K, Vranic M, Matthews SG.
    Endocrinology; 2002 May; 143(5):1761-8. PubMed ID: 11956158
    [Abstract] [Full Text] [Related]

  • 6. Neuroendocrine-immune disorder in type 2 diabetic patients with retinopathy.
    Obulkasim M, Turdi A, Amat N, Haxim M, Eziz R, Haji H, Li L, Chen X, Upur H, Ren J.
    Clin Exp Pharmacol Physiol; 2011 Apr; 38(4):229-32. PubMed ID: 21281334
    [Abstract] [Full Text] [Related]

  • 7. An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics.
    Costa A, Bono G, Martignoni E, Merlo P, Sances G, Nappi G.
    Psychoneuroendocrinology; 1996 Apr; 21(3):263-75. PubMed ID: 8817725
    [Abstract] [Full Text] [Related]

  • 8. A multivariate study of simultaneous escape from suppression by dexamethasone of urinary free cortisol, plasma cortisol, adrenocorticotropic hormone and beta-endorphin in melancholic patients.
    Maes M, Vandervorst C, Suy E, Minner B, Raus J.
    Acta Psychiatr Scand; 1991 Jun; 83(6):480-91. PubMed ID: 1652880
    [Abstract] [Full Text] [Related]

  • 9. Hypothalamo-pituitary-adrenal axis testing: nothing is sacred and caution in interpretation is needed.
    Dickstein G.
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):15-6. PubMed ID: 11167920
    [No Abstract] [Full Text] [Related]

  • 10. Hypothalamo-pituitary-adrenal axis and growth hormone axis in patients with rheumatoid arthritis.
    Demir H, Keleştimur F, Tunç M, Kirnap M, Ozügül Y.
    Scand J Rheumatol; 1999 Jan; 28(1):41-6. PubMed ID: 10092164
    [Abstract] [Full Text] [Related]

  • 11. [Clinical significance of the diagnostic use and assay of corticotropin-releasing hormone in the physiopathologic state of the hypothalamo-pituitary-adrenal axis].
    Nishikawa T, Yoshida A, Mikami K, Tamura Y, Yoshida S.
    Nihon Rinsho; 1990 Feb; 48 Suppl():182-4. PubMed ID: 2162415
    [No Abstract] [Full Text] [Related]

  • 12. Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients.
    Schüle C, Baghai T, Zwanzger P, Minov C, Padberg F, Rupprecht R.
    J Psychiatr Res; 2001 Feb; 35(4):239-47. PubMed ID: 11578642
    [Abstract] [Full Text] [Related]

  • 13. The hypothalamic-pituitary-adrenal axis in depression.
    Meltzer HY, Lowy MT, Koenig JI.
    Adv Biochem Psychopharmacol; 1987 Feb; 43():165-82. PubMed ID: 3035885
    [No Abstract] [Full Text] [Related]

  • 14. Effect of dexamethasone intravitreal implant on blood glucose, hypothalamic-pituitary-adrenal axis function and vascular endothelial growth factor serum levels in patients with diabetic macular oedema.
    Posch-Pertl L, Schwetz V, Michelitsch M, Rabensteiner J, Höller V, Gasser-Steiner V, Weger M, Sourij H.
    Acta Ophthalmol; 2018 Jun; 96(4):e543-e544. PubMed ID: 29220113
    [No Abstract] [Full Text] [Related]

  • 15. Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis.
    Heesen C, Gold SM, Raji A, Wiedemann K, Schulz KH.
    Psychoneuroendocrinology; 2002 May; 27(4):505-17. PubMed ID: 11912002
    [Abstract] [Full Text] [Related]

  • 16. Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy.
    Jenkins PJ, Sohaib SA, Trainer PJ, Lister TA, Besser GM, Reznek R.
    Br J Cancer; 1999 Aug; 80(11):1815-9. PubMed ID: 10468302
    [Abstract] [Full Text] [Related]

  • 17. The hypothalamus-pituitary-adrenal axis in HIV disease.
    Freda PU, Bilezikian JP.
    AIDS Read; 1999 Aug; 9(1):43-50. PubMed ID: 12728883
    [Abstract] [Full Text] [Related]

  • 18. Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS.
    Then Bergh F, Kümpfel T, Trenkwalder C, Rupprecht R, Holsboer F.
    Neurology; 1999 Sep 11; 53(4):772-7. PubMed ID: 10489039
    [Abstract] [Full Text] [Related]

  • 19. Post-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity.
    Schinke C, Hesse S, Stoppe M, Meyer K, Schmidt E, Orthgiess J, Bechmann L, Bresch A, Rullmann M, Luthardt J, Sabri O, Blüher M, Kratzsch J, Then Bergh F.
    Psychoneuroendocrinology; 2017 Apr 11; 78():39-47. PubMed ID: 28167369
    [Abstract] [Full Text] [Related]

  • 20. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone.
    Schroeder S, Wichers M, Klingmüller D, Höfer M, Lehmann LE, von Spiegel T, Hering R, Putensen C, Hoeft A, Stüber F.
    Crit Care Med; 2001 Feb 11; 29(2):310-6. PubMed ID: 11246311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.